Veeva Systems Inc.
VEEV · Healthcare · · USDFahodi Score BUY Long-term (Investment)
72
/ 100
Technical
75
Trend & RS
98
Momentum
84
Fundamental
89
Macro
24
Liquidity
59
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 10% |
| Trend & RS | 98.4 | 10% |
| Momentum | 83.6 | 5% |
| Fundamental | 88.9 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 59.4 | 20% |
Trade Setup
| Entry | 298.81 |
| Stop Loss | 279.51 (6.5%) |
| Target 1 (1:1) | 318.11 (+6.5%) |
| Target 2 (2:1) | 337.41 (+12.9%) |
| ATR(14) | 9.65 (3.2%) |
| Risk per Share | 19.30 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 11.4 | -1.54 | |
| Momentum | 83.6 | +1.34 | |
| Quality | 75.8 | +1.03 | |
| Composite | 56.9 | ||
Quality Scores
Piotroski F-Score
7
/9 —
Strong
✓
✓
✗
✗
✓
✓
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
200.84
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 50.8 | 22.0 | +131% above |
| P/B Ratio | 6.8 | 4.0 | Above |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
143.32
vs
Market Price
310.10
Upside
-53.8%
| Margin of Safety | -116.4% |
| Stage 1 PV (5yr FCF) | 4,990,043,886 |
| Terminal Value PV | 18,213,987,657 |
| Total Enterprise Value | 23,204,031,543 |
Assumptions
| Base FCF | 790,115,188 |
| Growth Rate (5yr) | 17.6% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
47.23%
Full Kelly
23.61%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 72/100. Estimated win rate 62%, avg win 9.3%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
47.4
RSI(14)
5.725
MACD
Relative Strength (RS) IMPROVING
95
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+32.3% vs SPY 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | No (10d since high) |
| Sector Outperformance | +14.5% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 47.4 | NEUTRAL |
| Macd | 5.725 | BEARISH |
| Ma Cross | 289.05 / 211.36 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.05x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 325.99 |
| Bollinger Upper | 327.69 |
| SMA(200) | 211.36 |
| SMA(50) | 289.05 |
| SMA(20) | 311.12 |
| Current Price | 310.10 |
| Bollinger Lower | 294.54 |
| 52-Week Low | 148.05 |
| ATR(14) | 9.65 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 0.92x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.94x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 0.96x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.42x | Normal bar — no special VSA pattern |
| 2026-11-06 | Normal | 0.05x | Normal bar — no special VSA pattern |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 307.00 | Above Kijun |
| Kijun-sen (26) | 299.41 | Base line |
| Senkou A | 303.20 | Leading span A |
| Senkou B | 282.46 | Leading span B |
| Cloud | 282.46 – 303.20 | Bullish (Green) |
| Price vs Cloud | 298.81 | Inside Cloud |
| Chikou Span | 273.33 | Bullish |
| Alignment Score | 3/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BEARISH
BB: 294.54 – 327.69 | KC: 296.34 – 325.9
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 205.69
Anchor: 2026-04-10 (52w Low)
ABOVE AVWAP
+45.3%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/VEEV
Valuation
| Metric | Value |
|---|---|
| Market Cap | 50.21B |
| P/E (TTM) | 50.84 |
| Forward P/E | N/A |
| P/B | 6.75 |
| EPS | 6.10 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 17.6% |
| Profit Margin | 29.3% |
| ROE | 14.4% |
| Debt/Equity | 2.04 |
| Current Ratio | 5.46 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 0.88 |
Trading Data
310.10
Open
310.10
Day High
310.10
Day Low
2.15M
Volume (1.3x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)